GSK plc (NYSE:GSK) on Wednesday announced plans to invest $30 billion across the United States in research and development and supply chain infrastructure over the next five years. The update includes ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Pennsylvania is providing GSK ...
GSK plans to invest $30 billion on research, development and supply chain infrastructure in the U.S. over the next five years. The plan includes $1.2 billion for new manufacturing facilities and ...
We recently published a list of Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against other best ...
INCHEON, South Korea, ROCKVILLE, Md. and LONDON , Dec. 21, 2025 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing ...
The Daily Overview on MSN
GSK grabs RAPT for $2.2B in big bet on food allergy drugs
GSK is staking billions on a new way to protect people from life‑threatening food allergies, agreeing to buy RAPT ...
The drug giant responded after a CBS "60 Minutes" report aired Sunday night in which a former Triangle-based GSK quality inspector Cheryl Eckard spoke at length publicly about production problems.
Secures the company's first U.S.-based manufacturing site, strengthening and diversifying its global supply network Additional investments planned to expand the site's capacity (currently at 60,000 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results